Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors
abstract: Osteosarcoma is the most common bone cancer in children and adolescents. Patients with metastatic osteosarcoma are typically refractory to treatment. Numerous lines of evidence suggest that cytotoxic T-lymphocytes (CTL) limit the development of metastatic osteosarcoma. I have investigated...
Other Authors: | Lussier, Danielle Marie (Author) |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.29627 |
Similar Items
-
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer
by: Tian Zhang, et al.
Published: (2021-02-01) -
Cell-mediated immunotherapy: its role in cancer treatment
by: Deshpande, Janhavee
Published: (2017) -
Modulation of innate immune mechanisms to enhance vaccine induced immunity: Role of co-inhibitory molecules
by: Sreenivas eGannavaram, et al.
Published: (2016-05-01) -
Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma
by: Chao Wang, et al.
Published: (2020-12-01) -
Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
by: Vicenç Ruiz de Porras, et al.
Published: (2021-04-01)